BFRA
$7.13
Biofrontera Ag ADR
($.04)
(.56%)
BFRA
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Wednesday
Feb 10
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BFRA reports earnings?
Beat
Meet
Miss

Where is BFRA's stock price going from here?
Up
Flat
Down
Stock chart of BFRA
Analysts
Summary of analysts' recommendations for BFRA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Biofrontera AG is a biopharmaceutical company. It engaged in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases. The company's products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions which can sometimes lead to skin cancer as well as the treatment of certain forms of basal cell carcinoma in the European Union. Biofrontera AG is based in Leverkusen, Germany.